Problems of drug safety: aristolochic acid
Hagemann, U.; Grase, R.; Thiele, A.; Bass, R.; Schönhöfer, P.S.
Münchener Medizinische Wochenschrift 124(25): 611-612
1982
ISSN/ISBN: 0341-3098 PMID: 6810142 Document Number: 186136
Document emailed within 1 workday
Related Documents
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261Wiessler, M. 1994: DNA adducts of pyrrolizidine alkaloids, nitroimidazoles and aristolochic acid Iarc Scientific Publications 125: 165-177
Siering, H.; Siering, U. 1984: Modification of the leukocyte adherence inhibition test by prednisolone and aristolochic acid Folia Haematologica 111(1): 27-31
Kluthe, R.; Vogt, A.; Batsford, S. 1982: Double blind study of the influence of aristolochic acid on granulocyte phagocytic activity Arzneimittel-Forschung 32(4): 443-445
Cao, J.; Yang, X.-d.; Wang, X.-y.; Qu, L.; Liu, G.; Li, X.-m. 2010: Differential changes of intrarenal oxygenation in rat models of acute tubular necrosis caused by aristolochic acid and gentamicin Zhonghua Yi Xue Za Zhi 90(17): 1208-1212
Zou, J.; Feng, J.-M.; Li, W.; Guo, W.; Wang, L.-N. 2008: Differentiation of mesenchymal stem cells into vascular endothelial cells in treatment of chronic aristolochic acid nephropathy: experiment with rats Zhonghua Yi Xue Za Zhi 88(10): 705-710
Tang, J.; Yao, J.; Shi, J.; Xiao, Q.; Zhou, J.; Chen, F. 2012: Synthesis, characterization, drug-loading capacity and safety of novel pH-independent amphiphilic amino acid copolymer micelles Die Pharmazie 67(9): 756-764
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Leonard, B. 1987: Drug safety and drug toxicity: the Irish situation Irish Medical Journal 80(4): 106-107
Bhatt, A.D. 1999: Drug-related problems and adverse drug events: negligence, litigation and prevention Journal of the Association of Physicians of India 47(7): 715-720
Zumbé, F.J.; Beck, K.J.; Schönhöfer, P.S. 1973: Gynecological-obstetrical problems in female drug users and drug addicts Geburtshilfe und Frauenheilkunde 33(4): 241-253
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Gladtke, E. 1981: Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage Die Medizinische Welt 32(7): 219-224
Kimbel, K.H. 1978: Drug safety through drug legislation Der Internist 19(6): 326-332
Grigsby, T.J.; Forster, M.; Baezconde-Garbanati, L.; Soto, D.W.; Unger, J.B. 2014: Do adolescent drug use consequences predict externalizing and internalizing problems in emerging adulthood as well as traditional drug use measures in a Hispanic sample? Addictive Behaviors 39(3): 644-651
Horváth, Z. 1973: Studies on the causes for drug abuse using ethylmorphine hydrochloride and acetylsalicylic-acid-containing drug combinations Die Pharmazie 28(4): 242-243
Yasuda, K.; Tsurumi, K.; Fujimura, H. 1986: Study of drug interaction between the new antiallergic drug 11-oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid and theophylline Arzneimittel-Forschung 36(11): 1642-1646
Liang, A.-h.; Ding, X.-s.; Liu, B.-y. 2004: Studies on the renal toxicity caused by aristolochic acids (AAs) and Chinese herbs containing AAs Zhongguo Zhong Yao Za Zhi 29(1): 10-14